Aytu Biopharma (AYTU) FCF Margin (2013 - 2026)
Aytu Biopharma's FCF Margin was 27.28% in fiscal Q4 2026 (quarter ended Jun 30, 2026), up 8.87 percentage points from 18.41% a year earlier and up 60.98 percentage points from the prior quarter.
Powered by 
Analysis
Aytu Biopharma (AYTU) FCF Margin (2013 - 2026) Analysis & Trends
For FY2026 (ended Jun 30, 2026), FCF Margin at Aytu Biopharma came in at 5.65%, up 8.91 percentage points from FY2025.
- FCF Margin shows a five-year change of +48.83 percentage points (FY2021 to FY2026).
- In earlier fiscal years, FCF Margin was -3.26% in FY2025 (-0.63 pp), -2.63% in FY2024 (+2.14 pp), -4.78% in FY2023 (+25.04 pp) and -29.82% in FY2022 (+13.37 pp).
- The fiscal Q4 2026 figure marks the highest quarterly FCF Margin since fiscal Q4 2023.
- Compared with a year earlier, FCF Margin has increased for five straight quarters, with an average year-over-year change of +3.08 percentage points over the last eight quarters.
- The best year-over-year quarter for FCF Margin over five years was fiscal Q4 2023 (a gain of 56.34 percentage points); the worst was fiscal Q3 2022 (a drop of 183.78 percentage points).
- Per Business Quant data, AYTU's FCF Margin in the three fiscal quarters before Q4 2026 was -33.70% (Q3 2026), 24.12% (Q2 2026) and -4.45% (Q1 2026).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,261.99 Bn | 1,235.61 Bn | 20.46 Bn | 33.69% |
| 2 | Johnson & Johnson | 678.93 Bn | 598.79 Bn | 17.30 Bn | 25.03% |
| 3 | AbbVie | 518.29 Bn | 486.30 Bn | 13.12 Bn | 41.97% |
| 4 | Merck | 365.98 Bn | 328.92 Bn | 13.19 Bn | 30.51% |
| 5 | Novartis Ag | 316.85 Bn | 290.09 Bn | - | - |
| 6 | Astrazeneca | 293.40 Bn | 267.29 Bn | 13.26 Bn | 52.85% |
| 7 | Amgen | 251.78 Bn | 203.43 Bn | 7.58 Bn | 35.25% |
| 8 | Gilead Sciences | 210.61 Bn | 185.71 Bn | 6.73 Bn | 57.81% |
| 9 | Pfizer | 166.87 Bn | 114.23 Bn | 12.56 Bn | 28.96% |
| 10 | Aytu Biopharma | 22.17 Mn | -93.50 Mn | 10.41 Mn | 27.28% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 27.28% |
| Mar 31, 2026 | -33.70% |
| Dec 31, 2025 | 24.12% |
| Sep 30, 2025 | -4.45% |
| Jun 30, 2025 | 18.41% |
| Mar 31, 2025 | -35.36% |
| Dec 31, 2024 | 17.87% |
| Sep 30, 2024 | -8.00% |
| Jun 30, 2024 | -7.65% |
| Mar 31, 2024 | -1.81% |
| Dec 31, 2023 | -0.72% |
| Sep 30, 2023 | -1.18% |
| Jun 30, 2023 | 30.49% |
| Mar 31, 2023 | -12.76% |
| Dec 31, 2022 | -9.33% |
| Sep 30, 2022 | -33.08% |
| Jun 30, 2022 | -25.85% |
| Mar 31, 2022 | -37.67% |
| Dec 31, 2021 | -38.11% |
| Sep 30, 2021 | -17.35% |
API Access
Aytu Biopharma FCF Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=fcf-margin&ticker=AYTU&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "fcf-margin", "ticker": "AYTU", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=fcf-margin&ticker=AYTU&period=max&api_key=YOUR_API_KEY");
const data = await res.json();